http://publicationslist.org/data/b.moum/atom.xml Bjorn Moumhttp://publicationslist.org/b.moum$basepathfavicon.icoRecent additions to Bjorn Moum's PublicationsList.org pagehttp://publicationslist.org/publications.png2010-06-19T08:21:43Z http://publicationslist.org/b.moum/refid2 2010-06-19T08:20:54Z

Jan G Hatlebakk, Frode Lerang, Bjørn Moum (2010) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 130: 6 <br/>

http://publicationslist.org/b.moum/refid3 2010-06-19T08:20:54Z

Bjørn Moum (2010) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 130: 5 <br/>

http://publicationslist.org/b.moum/refid8 2010-06-19T08:20:54Z

In this systematic review we focus on the current use of and knowledge on health related quality of life in unselected, population-based IBD cohorts. We made a systematic literature search and included for comprehensive review papers that described a population-based cohort and that used validated HRQoL instruments. We show that even studies defined by the authors as population-based do not always...<br/><br/>Marte Lie Hoivik, Tomm Bernklev, Bjorn Moum (2010) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 16: 3 525-536<br/>

http://publicationslist.org/b.moum/refid7 2010-06-19T08:20:54Z

BACKGROUND: The aims of this study were to explore the influences of familial, maternal, and paternal inflammatory disease (IBD) on perinatal outcomes in the offspring and the risk for development of IBD related to perinatal factors. METHODS: Eighty-five patients with Crohn's disease (CD) and 86 with ulcerative colitis (UC) were included from a population-based incidence study enrolled 1990-1994. ...<br/><br/>May-Bente Bengtson, Inger Camilla Solberg, Geir Aamodt, Jørgen Jahnsen, Bjørn Moum, Morten H Vatn (2010) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 16: 5 847-855<br/>

http://publicationslist.org/b.moum/refid1 2010-06-19T08:20:54Z

Bjørn Moum, Jørgen Jahnsen (2010) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 130: 6 638-639<br/>

http://publicationslist.org/b.moum/refid4 2010-06-19T08:20:54Z

BACKGROUND: Forecasting clinical and economic outcomes in ulcerative colitis (UC) and Crohn's disease (CD) patients is complex, but necessary. AIMS: To determine: the frequency of treatment-classified clinical states; the probability of transition between states; and the economic outcomes. METHODS: Newly diagnosed UC and CD patients, allocated into seven clinical states by medical and surgical tre...<br/><br/>S Odes, H Vardi, M Friger, D Esser, F Wolters, B Moum, H Waters, M Elkjaer, T Bernklev, E Tsianos, C O'Morain, R Stockbrügger, P Munkholm, E Langholz (2010) <i>Aliment Pharmacol Ther</i> <i></i> <i></i> 31: 7 735-744<br/>

http://publicationslist.org/b.moum/refid56 2010-06-19T08:20:54Z

BACKGROUND: Perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) are proposed to be specific markers for ulcerative colitis (UC) and Crohn's disease (CD). Their prevalence and relationship to disease phenotype and outcome in unselected cohorts of patients with inflammatory bowel disease (IBD), however, is largely unclear. We studied the prev...<br/><br/>Inger Camilla Solberg, Idar Lygren, Milada Cvancarova, Jørgen Jahnsen, Njaal Stray, Jostein Sauar, Stefan Schreiber, Bjørn Moum, Morten H Vatn (2009) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 15: 3 406-414<br/>

http://publicationslist.org/b.moum/refid5 2010-06-19T08:20:54Z

Tom Øresland, Bjørn Moum (2009) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 129: 22 2389-2390<br/>

http://publicationslist.org/b.moum/refid6 2010-06-19T08:20:54Z

Bjørn Moum, Jørgen Jahnsen, Tomm Bernklev (2009) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 16: 7 1091-1092<br/>

http://publicationslist.org/b.moum/refid10 2010-06-19T08:20:54Z

OBJECTIVE: Cohort studies of unselected and newly diagnosed patients are essential for a better understanding of the prognosis in ulcerative colitis (UC). The aim of this study was to evaluate the course of UC in a population-based inception cohort during the first 10 years, and to identify prognostic risk factors based on information gathered at diagnosis. MATERIAL AND METHODS: From 1990 to 1994,...<br/><br/>Inger Camilla Solberg, Idar Lygren, Jørgen Jahnsen, Erling Aadland, Ole Høie, Milada Cvancarova, Tomm Bernklev, Magne Henriksen, Jostein Sauar, Morten H Vatn, Bjørn Moum (2009) <i>Scand J Gastroenterol</i> <i></i> <i></i> 44: 4 431-440<br/>

http://publicationslist.org/b.moum/refid9 2010-06-19T08:20:54Z

BACKGROUND:: The aim was to compare clustering of time at diagnosis and phenotype of inflammatory bowel disease (IBD) between affected parents and children and to explore generational differences in age at diagnosis (AAD) as well as the concordance of clinical characteristics. METHODS:: Eighty-four affected pairs from 45 families were included from 5 counties in southeastern Norway between August ...<br/><br/>May-Bente Bengtson, Camilla Solberg, Geir Aamodt, Jørgen Jahnsen, Bjørn Moum, Jostein Sauar, Morten H Vatn (2009) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 15: 12 1867-1874<br/>

http://publicationslist.org/b.moum/refid60 2010-06-19T08:20:54Z

BACKGROUND: The purpose was to study the spatial distribution of cases of inflammatory bowel disease (IBD) and characterize municipalities with high incidences in a search for environmental risk factors. METHODS: Spatial clustering of patients diagnosed with IBD during 1990-1993 were studied in 4 counties in southeastern Norway, and an ecological analysis was conducted to study the relationship be...<br/><br/>Geir Aamodt, Jørgen Jahnsen, May-Bente Bengtson, Bjørn Moum, Morten H Vatn (2008) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 14: 7 984-991<br/>

http://publicationslist.org/b.moum/refid58 2010-06-19T08:20:54Z

Inflammatory bowel disease refers to a group of chronic diseases of unknown etiology related to both genetic and environmental factors. In this 1990-1993 study, the authors investigated associations between the content and quality of drinking water and the incidence of inflammatory bowel disease. They used data from a population-based cohort recruited in southeastern Norway and a registry of water...<br/><br/>Geir Aamodt, Geir Bukholm, Jørgen Jahnsen, Bjørn Moum, Morten H Vatn (2008) <i>Am J Epidemiol</i> <i></i> <i></i> 168: 9 1065-1072<br/>

http://publicationslist.org/b.moum/refid59 2010-06-19T08:20:54Z

BACKGROUND AND AIMS: C-reactive protein (CRP) levels are often used in the follow-up of patients with inflammatory bowel disease (IBD). The aims of this study were to establish the relationship of CRP levels to disease extent in patients with ulcerative colitis and to phenotype in patients with Crohn's disease, and to investigate the predictive value of CRP levels for disease outcome. METHODS: CRP...<br/><br/>M Henriksen, J Jahnsen, I Lygren, N Stray, J Sauar, M H Vatn, B Moum (2008) <i>Gut</i> <i></i> <i></i> 57: 11 1518-1523<br/>

http://publicationslist.org/b.moum/refid57 2010-06-19T08:20:54Z

Bjørn Moum (2008) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 14 Suppl 2: S212-S213<br/>

http://publicationslist.org/b.moum/refid66 2010-06-19T08:20:54Z

OBJECTIVE: To determine dysplasia and cancer in the 1991-2004 European Collaborative Inflammatory Bowel Disease (EC-IBD) Study Group cohort. PATIENTS AND METHODS: A patient questionnaire and a physician per patient form were completed for each of the 1,141 inflammatory bowel disease patients (776 ulcerative colitis/365 Crohn's disease) from 9 centers (7 countries) derived from the EC-IBD cohort. R...<br/><br/>K H Katsanos, S Vermeire, D K Christodoulou, L Riis, F Wolters, S Odes, J Freitas, Ole Hoie, Marina Beltrami, G Fornaciari, J Clofent, P Bodini, M Vatn, Paula Borralho Nunes, B Moum, P Munkholm, C Limonard, R Stockbrugger, P Rutgeerts, E V Tsianos (2007) <i>Digestion</i> <i></i> <i></i> 75: 2-3 113-121<br/>

http://publicationslist.org/b.moum/refid67 2010-06-19T08:20:54Z

BACKGROUND: The influence of familial IBD on phenotype and course of disease in patients with CD and UC has not been studied in population-based cohorts. AIM: To compare phenotype and course of disease between IBD patients with a first-degree relative with IBD and sporadic cases in a population-based cohort followed prospectively for 5 yr. METHODS: Family history of IBD was registered at diagnosis...<br/><br/>Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Morten H Vatn, Bjørn Moum (2007) <i>Am J Gastroenterol</i> <i></i> <i></i> 102: 9 1955-1963<br/>

http://publicationslist.org/b.moum/refid69 2010-06-19T08:20:54Z

OBJECTIVES: Cumulative 10-yr relapse rates in ulcerative colitis (UC) of 70% to almost 100% have been reported in regional studies. The aim of this study was to determine the relapse rate in UC in a European population-based cohort 10 yr after diagnosis and to identify factors that may influence the risk of relapse. METHODS: From 1991 to 1993, 771 patients with UC from seven European countries and...<br/><br/>Ole Höie, Frank Wolters, Lene Riis, Geir Aamodt, Camilla Solberg, Tomm Bernklev, Selwyn Odes, Iannis A Mouzas, Marina Beltrami, Ebbe Langholz, Reinhold Stockbrügger, Morten Vatn, Bjorn Moum (2007) <i>Am J Gastroenterol</i> <i></i> <i></i> 102: 8 1692-1701<br/>

http://publicationslist.org/b.moum/refid65 2010-06-19T08:20:54Z

B Moum, Z Konopski, K F Tufteland, J Jahnsen (2007) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 13: 12 1584-1586<br/>

http://publicationslist.org/b.moum/refid63 2010-06-19T08:20:54Z

BACKGROUND: Colorectal cancer is a complication of longstanding inflammatory bowel disease. The association between cancer and inflammation is best documented in ulcerative colitis, but an increased risk of cancer is also found in patients with Crohn's disease. Surveillance with colonoscopy is commonly used to detect dysplasia and early cancer in patients with in ulcerative colitis. There has been...<br/><br/>Magne Henriksen, Bjørn Moum (2007) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 127: 20 2696-2699<br/>

http://publicationslist.org/b.moum/refid61 2010-06-19T08:20:54Z

BACKGROUND & AIMS: Most studies concerning the clinical course in CD are retrospective or based on selected patient groups. Our aim was to assess the course of CD in a prospective population-based follow-up study and to identify possible prognostic risk factors for complications on the basis of information obtained at initial diagnosis. METHODS: From 1990-1994, a population-based cohort of 843 new...<br/><br/>Inger Camilla Solberg, Morten H Vatn, Ole Høie, Njaal Stray, Jostein Sauar, Jørgen Jahnsen, Bjørn Moum, Idar Lygren (2007) <i>Clin Gastroenterol Hepatol</i> <i></i> <i></i> 5: 12 1430-1438<br/>

http://publicationslist.org/b.moum/refid62 2010-06-19T08:20:54Z

Bjørn Moum (2007) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 127: 21 2841-2842<br/>

http://publicationslist.org/b.moum/refid70 2010-06-19T08:20:54Z

BACKGROUND: There are few population-based, prospective studies on the clinical course in patients with Crohn's disease (CD). AIM: To extend the observation period in a population-based prospective study (the IBSEN study) to find out more about the initial 5-year clinical course in CD patients and to relate the findings to the Vienna classification. METHODS: All patients diagnosed with inflammator...<br/><br/>Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Erling Aadland, Tom Schulz, Morten H Vatn, Bjørn Moum (2007) <i>Scand J Gastroenterol</i> <i></i> <i></i> 42: 5 602-610<br/>

http://publicationslist.org/b.moum/refid64 2010-06-19T08:20:54Z

BACKGROUND AND AIMS: Mucosal healing (MH) in inflammatory bowel disease may be an important sign of efficacy of treatment and a prognostic marker of long-term disease. The aim of the study was to examine both the possible predictors of mucosal healing and the impact of healing on subsequent course of disease. METHODS: In 740 incident patients diagnosed with ulcerative colitis (UC) or Crohn's disea...<br/><br/>Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn A Moum, Morten H Vatn (2007) <i>Gastroenterology</i> <i></i> <i></i> 133: 2 412-422<br/>

http://publicationslist.org/b.moum/refid68 2010-06-19T08:20:54Z

Bjørn Moum (2007) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 127: 12 <br/>

http://publicationslist.org/b.moum/refid71 2010-06-19T08:20:54Z

OBJECTIVE: Geographic differences in disease course of Crohn's disease (CD) might possibly be related to differences in genetic and environmental factors encountered in different parts of the world. The aim of this study was to assess differences in treatment regimens within a European cohort of CD patients as a reflection of disease course, and to identify associated phenotypic risk factors at di...<br/><br/>Frank L Wolters, Catelijne Joling, Maurice G Russel, Jildou Sijbrandij, Marion De Bruin, Selwyn Odes, Lene Riis, Pia Munkholm, Paolo Bodini, Barbara Ryan, Colm O'Morain, Ioannis A Mouzas, Epameinondas Tsianos, Severine Vermeire, Estela Monteiro, Charles Limonard, Morten Vatn, Giovanni Fornaciari, Dolores Rodriguez, Wim Groot, Bjørn Moum, Reinhold W Stockbrügger (2007) <i>Scand J Gastroenterol</i> <i></i> <i></i> 42: 3 333-344<br/>

http://publicationslist.org/b.moum/refid76 2010-06-19T08:20:54Z

BACKGROUND: Population based studies have revealed varying mortality for patients with ulcerative colitis but most have described patients from limited geographical areas who were diagnosed before 1990. AIMS: To assess overall mortality in a European cohort of patients with ulcerative colitis, 10 years after diagnosis, and to investigate national ulcerative colitis related mortality across Europe....<br/><br/>O Höie, L J Schouten, F L Wolters, I C Solberg, L Riis, I A Mouzas, P Politi, S Odes, E Langholz, M Vatn, R W Stockbrügger, B Moum (2007) <i>Gut</i> <i></i> <i></i> 56: 4 497-503<br/>

http://publicationslist.org/b.moum/refid74 2010-06-19T08:20:54Z

BACKGROUND AND AIM: The aetiology of inflammatory bowel disease (IBD) is unknown, but it has become evident that genetic factors are involved in disease susceptibility. Studies have suggested a north-south gradient in the incidence of IBD, raising the question whether this difference is caused by genetic heterogeneity. We aimed to investigate the prevalence of polymorphisms in CARD15 and TLR4 and ...<br/><br/>Lene Riis, Ida Vind, Severine Vermeire, Frank Wolters, Kostas Katsanos, Patrizia Politi, João Freitas, Ioannis A Mouzas, Colm O'Morain, Victor Ruiz-Ochoa, Selwyn Odes, Vibeke Binder, Pia Munkholm, Bjørn Moum, Reinhold Stockbrügger, Ebbe Langholz (2007) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 13: 1 24-32<br/>

http://publicationslist.org/b.moum/refid73 2010-06-19T08:20:54Z

BACKGROUND & AIMS: The colectomy rate in ulcerative colitis (UC) is related to morbidity and to treatment decisions made during disease course. The aims of this study were to determine the colectomy risk in UC in the first decade after diagnosis and to identify factors that may influence the choice of surgical treatment. METHODS: In 1991-1993, 781 UC patients from 9 centers located in 7 countries ...<br/><br/>Ole Hoie, Frank L Wolters, Lene Riis, Tomm Bernklev, Geir Aamodt, Juan Clofent, Epaminondas Tsianos, Marina Beltrami, Selwyn Odes, Pia Munkholm, Morten Vatn, Reinhold W Stockbrügger, Bjorn Moum (2007) <i>Gastroenterology</i> <i></i> <i></i> 132: 2 507-515<br/>

http://publicationslist.org/b.moum/refid72 2010-06-19T08:20:54Z

BACKGROUND: NOD2/CARD15, the first identified susceptibility gene in Crohn's disease (CD), is associated with ileal stenosis and increased frequency of surgery. Anti-Saccharomyces cerevisiae antibody (ASCA), a serological marker for CD, is associated with ileal location and a high likelihood for surgery. We hypothesized that the presence of ASCA and NOD2/CARD15 mutations could predict increased he...<br/><br/>Shmuel Odes, Michael Friger, Hillel Vardi, Greet Claessens, Xavier Bossuyt, Lene Riis, Pia Munkholm, Frank Wolters, Hagit Yona, Ole Hoie, Marina Beltrami, Epameinondas Tsianos, Kostas Katsanos, Ioannis Mouzas, Juan Clofent, Estela Monteiro, Andrea Messori, Patrizia Politi, Colm O'Morain, Charles Limonard, Maurice Russel, Morten Vatn, Bjorn Moum, Reinhold Stockbrugger, Severine Vermeire (2007) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 13: 7 874-881<br/>

http://publicationslist.org/b.moum/refid83 2010-06-19T08:20:54Z

BACKGROUND: The goal of this study was to determine the rate of work disability, unemployment, and sick leave in an unselected inflammatory bowel disease (IBD) cohort and to measure the effect of working status and disability on the patient's health-related quality of life (HRQOL). MATERIALS AND METHODS: All eligible patients were clinically examined and interviewed at the 5-year follow-up visit. ...<br/><br/>Tomm Bernklev, Jørgen Jahnsen, Magne Henriksen, Idar Lygren, Erling Aadland, Jostein Sauar, Tom Schulz, Njål Stray, Morten Vatn, Bjørn Moum (2006) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 12: 5 402-412<br/>

http://publicationslist.org/b.moum/refid82 2010-06-19T08:20:54Z

BACKGROUND: The insertion of self-expanding metal stents (SEMS) for palliation of dysphagia in patients with malignant stenosis of the esophagus and cardia, is a well-established procedure. The aim of this retrospective study was to evaluate the results of esophageal stenting in terms of functioning, need of retreatment and survival after stenting. PATIENTS AND METHODS: 37 patients with unresectab...<br/><br/>Morten Tangen, Svend J Andresen, Bjørn Moum, Truls Hauge (2006) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 126: 12 1607-1609<br/>

http://publicationslist.org/b.moum/refid84 2010-06-19T08:20:54Z

The first gene associated with Crohn disease (CD) has been identified as CARD15 (16q12). Three variants, R702W, G908R and 1007fsinsC are strongly and independently associated with the disease. A second gene, conveying a smaller risk for inflammatory bowel disease (IBD), has been identified as DLG5 (10q23). We assess the frequency of the CARD15 SNPs and of the R30Q mutation in DLG5 and their contri...<br/><br/>Valentina Medici, Silvia Mascheretti, Peter J P Croucher, Monika Stoll, Jochen Hampe, Jochen Grebe, Giacomo C Sturniolo, Camilla Solberg, Jorgen Jahnsen, Bjorn Moum, Stefan Schreiber, Morten H Vatn (2006) <i>Eur J Hum Genet</i> <i></i> <i></i> 14: 4 459-468<br/>

http://publicationslist.org/b.moum/refid86 2010-06-19T08:20:54Z

BACKGROUND: In Crohn's disease (CD), studies associating phenotype at diagnosis and subsequent disease activity are important for patient counselling and health care planning. AIMS: To calculate disease recurrence rates and to correlate these with phenotypic traits at diagnosis. METHODS: A prospectively assembled uniformly diagnosed European population based inception cohort of CD patients was cla...<br/><br/>F L Wolters, M G Russel, J Sijbrandij, T Ambergen, S Odes, L Riis, E Langholz, P Politi, A Qasim, I Koutroubakis, E Tsianos, S Vermeire, J Freitas, G van Zeijl, O Hoie, T Bernklev, M Beltrami, D Rodriguez, R W Stockbrügger, B Moum (2006) <i>Gut</i> <i></i> <i></i> 55: 8 1124-1130<br/>

http://publicationslist.org/b.moum/refid89 2010-06-19T08:20:54Z

BACKGROUND: No previous correlation between phenotype at diagnosis of Crohn's disease (CD) and mortality has been performed. We assessed the predictive value of phenotype at diagnosis on overall and disease related mortality in a European cohort of CD patients. METHODS: Overall and disease related mortality were recorded 10 years after diagnosis in a prospectively assembled, uniformly diagnosed Eu...<br/><br/>F L Wolters, M G Russel, J Sijbrandij, L J Schouten, S Odes, L Riis, P Munkholm, P Bodini, C O'Morain, I A Mouzas, E Tsianos, S Vermeire, E Monteiro, C Limonard, M Vatn, G Fornaciari, S Pereira, B Moum, R W Stockbrügger (2006) <i>Gut</i> <i></i> <i></i> 55: 4 510-518<br/>

http://publicationslist.org/b.moum/refid85 2010-06-19T08:20:54Z

This article reports quality of life (QoL) aspects of a study that investigated the efficacy of three treatment regimens in gastro-oesophageal reflux disease patients. Following a 4-week symptom-control phase (esomeprazole 40 mg once daily), patients were randomised to 6 months' esomeprazole 20 mg once daily continuously (n = 658), on-demand (n = 634) or ranitidine 150 mg twice daily continuously ...<br/><br/>A N Hansen, R Bergheim, H Fagertun, H Lund, I Wiklund, B Moum (2006) <i>Int J Clin Pract</i> <i></i> <i></i> 60: 1 15-22<br/>

http://publicationslist.org/b.moum/refid81 2010-06-19T08:20:54Z

OBJECTIVE: To give a general outline of a 10-year clinical follow-up study of a population-based European cohort of inflammatory bowel disease (IBD) patients and to present the first results in terms of clinical outcome parameters and risk factors. MATERIALS AND METHODS: A population-based cohort of newly, prospectively, diagnosed cases was initiated between 1991 and 1993. The 2201 patients with I...<br/><br/>Frank L Wolters, Maurice G Russel, Jildou Sijbrandij, Leo J Schouten, Selwyn Odes, Lene Riis, Pia Munkholm, Ebbe Langholz, Paolo Bodini, Colm O'Morain, Kostas Katsanos, Epameinondas Tsianos, Severine Vermeire, Gilbert Van Zeijl, Charles Limonard, Ole Hoie, Morten Vatn, Bjørn Moum, Reinhold W Stockbrügger, The European Collaborative Study Group On Inflammatory Bowel Disease (2006) <i>Scand J Gastroenterol Suppl</i> <i></i> <i></i> : 243 46-54<br/>

http://publicationslist.org/b.moum/refid75 2010-06-19T08:20:54Z

Bjørn Moum (2006) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 126: 21 <br/>

http://publicationslist.org/b.moum/refid77 2010-06-19T08:20:54Z

BACKGROUND & AIMS: Economic analysis in chronic diseases is a prerequisite for planning a proper distribution of health care resources. We aimed to determine the cost of inflammatory bowel disease, a lifetime illness with considerable morbidity. METHODS: We studied 1321 patients from an inception cohort in 8 European countries and Israel over 10 years. Data on consumption of resources were obtaine...<br/><br/>Selwyn Odes, Hillel Vardi, Michael Friger, Frank Wolters, Maurice G Russel, Lene Riis, Pia Munkholm, Patrizia Politi, Epameinondas Tsianos, Juan Clofent, Severine Vermeire, Estela Monteiro, Iannis Mouzas, Giovanni Fornaciari, Jildou Sijbrandij, Charles Limonard, Gilbert Van Zeijl, Colm O'morain, Bjørn Moum, Morten Vatn, Reinhold Stockbrugger (2006) <i>Gastroenterology</i> <i></i> <i></i> 131: 3 719-728<br/>

http://publicationslist.org/b.moum/refid78 2010-06-19T08:20:54Z

OBJECTIVE: An exact diagnosis of inflammatory bowel disease (IBD) and further subclassification may be difficult even after clinical, radiological and histological examinations. A correct subclassification is important for the success of both medical and surgical therapeutic strategies, but there is a dearth of information available on the frequency of changes in diagnosis in population-based stud...<br/><br/>Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Jostein Sauar, Tom Schulz, Njål Stray, Morten H Vatn, Bjørn Moum, Ibsen Study Group (2006) <i>Scand J Gastroenterol</i> <i></i> <i></i> 41: 9 1037-1043<br/>

http://publicationslist.org/b.moum/refid79 2010-06-19T08:20:54Z

BACKGROUND AND AIMS: Inflammatory bowel disease (IBD) often affects patients in their fertile age. The aim of this study was to describe pregnancy outcome in a European cohort of IBD patients. As data are limited regarding the effect of pregnancy on disease course, our second objective was to investigate whether pregnancy influences disease course and phenotype in IBD patients. METHODS: In a Europ...<br/><br/>Lene Riis, Ida Vind, Patrizia Politi, Frank Wolters, Severine Vermeire, Epameinondas Tsianos, João Freitas, Ioannis Mouzas, Victor Ruiz Ochoa, Colm O'Morain, Selwyn Odes, Vibeke Binder, Bjørn Moum, Reinhold Stockbrügger, Ebbe Langholz, Pia Munkholm (2006) <i>Am J Gastroenterol</i> <i></i> <i></i> 101: 7 1539-1545<br/>

http://publicationslist.org/b.moum/refid80 2010-06-19T08:20:54Z

BACKGROUND: The majority of studies concerning the clinical course and prognosis in ulcerative colitis (UC) are old, retrospective in design, or hospital based. We aimed to identify clinical course and prognosis in a prospective, population-based follow-up study MATERIALS AND METHODS: Patients diagnosed with inflammatory bowel disease (IBD) or possible IBD in southeastern Norway during the period ...<br/><br/>Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Jostein Sauar, Øystein Kjellevold, Tom Schulz, Morten H Vatn, Bjørn Moum (2006) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 12: 7 543-550<br/>

http://publicationslist.org/b.moum/refid88 2010-06-19T08:20:54Z

Bjørn Moum, Anders Ekbom (2005) <i>Scand J Gastroenterol</i> <i></i> <i></i> 40: 8 881-885<br/>

http://publicationslist.org/b.moum/refid87 2010-06-19T08:20:54Z

BACKGROUND: We compared health-related quality of life (HRQOL) in a population-based cohort of Norwegian patients with inflammatory bowel disease (IBD) with a normal reference population by means of the short form-36 (SF-36) questionnaire, including the effect of age, sex, educational status, and symptom severity and the psychometric properties of the questionnaire. METHODS: The SF-36 was self-adm...<br/><br/>Tomm Bernklev, Jørgen Jahnsen, Idar Lygren, Magne Henriksen, Morten Vatn, Bjørn Moum (2005) <i>Inflamm Bowel Dis</i> <i></i> <i></i> 11: 10 909-918<br/>

http://publicationslist.org/b.moum/refid92 2010-06-19T08:20:54Z

One option for patients with symptoms of gastroesophageal reflux disease (GERD) is treatment with proton pump inhibitors without prior endoscopy. Continuous or on-demand maintenance therapy are options for symptom-free patients. This study assessed the efficacy of three different treatment options in GERD patients in Norway. About 395 General Practitioners enrolled 2156 patients with symptoms of G...<br/><br/>A Norman Hansen, R Bergheim, H Fagertun, H Lund, B Moum (2005) <i>Int J Clin Pract</i> <i></i> <i></i> 59: 6 665-671<br/>

http://publicationslist.org/b.moum/refid91 2010-06-19T08:20:54Z

OBJECTIVE: To describe the prevalence and characteristics of non-inflammatory joint pain (NIJP) in patients with chronic inflammatory bowel disease (IBD) and its impact on patients' health related quality of life (HRQOL). METHODS: In a population based cohort, 521 patients (80%) were clinically investigated 6 years after onset of IBD. NIJP was defined as a history of joint pain during the last 3 m...<br/><br/>Øyvind Palm, Tomm Bernklev, Bjørn Moum, Jan Tore Gran (2005) <i>J Rheumatol</i> <i></i> <i></i> 32: 9 1755-1759<br/>

http://publicationslist.org/b.moum/refid93 2010-06-19T08:20:54Z

This study assesses the difference in direct medical costs between on-demand treatment with esomeprazole 20 mg, continuous treatment with esomeprazole 20 mg once-daily and continuous treatment with ranitidine 150 mg twice-daily to prevent symptomatic relapse in patients with gastroesophageal reflux disease over 26 weeks. Two hundred eighty-one GP clinics in Norway enrolled 2156 patients to an open...<br/><br/>A N Hansen, P Wahlqvist, E Jørgensen, R Bergheim, H Fagertun, H Lund, B Moum (2005) <i>Int J Clin Pract</i> <i></i> <i></i> 59: 6 655-664<br/>

http://publicationslist.org/b.moum/refid90 2010-06-19T08:20:54Z

OBJECTIVES: We assessed health-related quality of life (HRQOL) on the basis of a cross-sectional design in a population-based cohort of inflammatory bowel disease patients followed prospectively for 5 years after diagnosis. The aim was to investigate the influence of the course of disease, drug therapy, and relapse pattern on the patients' HRQOL. METHODS: All patients completed the validated Norwe...<br/><br/>Tomm Bernklev, Jørgen Jahnsen, Tom Schulz, Jostein Sauar, Idar Lygren, Magne Henriksen, Njål Stray, Øystein Kjellevold, Erling Aadland, Morten Vatn, Bjørn Moum (2005) <i>Eur J Gastroenterol Hepatol</i> <i></i> <i></i> 17: 10 1037-1045<br/>

http://publicationslist.org/b.moum/refid11 2010-06-19T08:20:54Z

BACKGROUND: Health-related quality of life (HRQOL) has become an important tool in evaluating patient satisfaction in inflammatory bowel disease (IBD). So far, few prospective follow-up studies have been done to identify variables that influence HRQOL. We aimed to identify demographic and clinical variables that influence HRQOL 5 years after diagnosis in patients with ulcerative colitis (UC) or Cr...<br/><br/>T Bernklev, J Jahnsen, E Aadland, J Sauar, T Schulz, I Lygren, M Henriksen, N Stray, O Kjellevold, M Vatn, B Moum (2004) <i>Scand J Gastroenterol</i> <i></i> <i></i> 39: 4 365-373<br/>

http://publicationslist.org/b.moum/refid94 2010-06-19T08:20:54Z

OBJECTIVES: Few prospective population-based studies have been carried out on the incidence of inflammatory bowel disease (IBD). In a population-based study of pediatric IBD in southeastern Norway, patients <16 years at the time of diagnosis were followed up prospectively. The study reports on changes in diagnosis and clinical outcome 5 years after diagnosis. METHODS: From 1990 to 1993 new cases o...<br/><br/>Ketil Størdal, Jørgen Jahnsen, Beint S Bentsen, Bjørn Moum (2004) <i>Digestion</i> <i></i> <i></i> 70: 4 226-230<br/>

http://publicationslist.org/b.moum/refid95 2010-06-19T08:20:54Z

BACKGROUND: Patients with endoscopy-negative reflux disease have reflux symptoms, mainly heartburn, but not mucosal breaks characteristic of erosive oesophagitis. Standard-dose proton pump inhibitors can provide symptom relief in endoscopy-negative reflux disease but the effect of greater acid suppression has not been studied. AIM: To test the hypothesis that esomeprazole produces heartburn resolu...<br/><br/>D Armstrong, N J Talley, K Lauritsen, B Moum, T Lind, H Tunturi-Hihnala, T Venables, J Green, M A Bigard, J Mössner, O Junghard (2004) <i>Aliment Pharmacol Ther</i> <i></i> <i></i> 20: 4 413-421<br/>

http://publicationslist.org/b.moum/refid12 2010-06-19T08:20:54Z

BACKGROUND: Ulcerative colitis and Cohn's disease are characterised by exacerbations and remissions. Their aetiology is not known and treatment modalities are therefore focused on the inflammation. MATERIAL AND METHODS: A review is given of the literature on the clinical efficacy and safety of treatment with 5-aminosalicylates. RESULTS: Aminosalicylic acid has a well-documented efficacy in the acu...<br/><br/>Bjørn Moum (2003) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 123: 18 2565-2567<br/>

http://publicationslist.org/b.moum/refid13 2010-06-19T08:20:54Z

BACKGROUND AND STUDY AIMS: The text report is the primary tool for documenting endoscopic findings but there is no consensus on the content and structure of these reports. Therefore, at four Norwegian hospitals, the content of endoscopy reports concerning ulcerative colitis was assessed. Quality indices for the medical history of active ulcerative colitis and endoscopic signs of inflammation were ...<br/><br/>T de Lange, B A Moum, J K Tholfsen, S Larsen, L Aabakken (2003) <i>Endoscopy</i> <i></i> <i></i> 35: 10 835-840<br/>

http://publicationslist.org/b.moum/refid19 2010-06-19T08:20:54Z

BACKGROUND: Most incidence studies of ulcerative colitis (UC) and Crohn disease (CD) have dealt with adults and there are have been few population-based prospective studies of the incidence of inflammatory bowel disease (IBD) in children. The aim of this study was to determine the incidence after re-evaluation of the diagnosis of UC and CD in childhood and adolescence in a prospective population-b...<br/><br/>B S Bentsen, B Moum, A Ekbom (2002) <i>Scand J Gastroenterol</i> <i></i> <i></i> 37: 5 540-545<br/>

http://publicationslist.org/b.moum/refid20 2010-06-19T08:20:54Z

BACKGROUND: Crohn's disease is a heterogeneous disorder for which NOD2 (CARD 15) has been identified as a susceptibility gene. We investigate the relation between NOD2 genotype and phenotypic characteristics of patients with Crohn's disease. METHODS: Hypotheses about the relation between NOD2 genotype and Crohn's disease phenotype were generated retrospectively from a group of 446 German patients ...<br/><br/>Jochen Hampe, Jochen Grebe, Susanna Nikolaus, Camilla Solberg, Peter J P Croucher, Silvia Mascheretti, Jörgen Jahnsen, Björn Moum, Bodo Klump, Michael Krawczak, Muddassar M Mirza, Ulrich R Foelsch, Morten Vatn, Stefan Schreiber (2002) <i>Lancet</i> <i></i> <i></i> 359: 9318 1661-1665<br/>

http://publicationslist.org/b.moum/refid21 2010-06-19T08:20:54Z

OBJECTIVE: To study the occurrence of spondyloarthropathies (SpA) in patients with inflammatory bowel disease (IBD) seen 6 years after IBD diagnosis. METHODS: In a population based cohort of 654 patients with IBD, 521 patients (80%) were investigated, which included a complete rheumatological examination. Radiographs of the sacroiliac joints and lumbar spine were performed in 406 of these patients...<br/><br/>Oyvind Palm, Bjørn Moum, Aksel Ongre, Jan Tore Gran (2002) <i>J Rheumatol</i> <i></i> <i></i> 29: 3 511-515<br/>

http://publicationslist.org/b.moum/refid17 2010-06-19T08:20:54Z

BACKGROUND: There are few data on how patients on maintenance treatment of reflux oesophagitis take their medication. This study was designed to investigate the dosing patterns of patients on on-demand treatment and to compare lansoprazole with omeprazole in this regard. METHODS: Patients with reflux oesophagitis, initially treated until absence of symptoms, took capsules of either lansoprazole (3...<br/><br/>F Johnsson, B Moum, M Vilien, O Grove, M Simren, M Thoring (2002) <i>Scand J Gastroenterol</i> <i></i> <i></i> 37: 6 642-647<br/>

http://publicationslist.org/b.moum/refid18 2010-06-19T08:20:54Z

The causes and mechanisms of action of inflammatory bowel disease have, so far, eluded discovery. Epidemiological studies have shown that ulcerative colitis tends to level off, whereas Crohn's disease tends to increase. Some of these changes may be due to diagnostic practices and increasing awareness of the disease and Crohn's colitis. The disease varies according to geographical location and a di...<br/><br/>B Moum, A Ekbom (2002) <i>Dig Liver Dis</i> <i></i> <i></i> 34: 5 364-369<br/>

http://publicationslist.org/b.moum/refid14 2010-06-19T08:20:54Z

BACKGROUND: Colonoscopy screening has been recommended as the method for preventing the development of cancer in ulcerative colitis. Factors that increase the risk of developing cancer are early onset of the disease, widespread disease, and a duration of over 10 years. MATERIAL AND METHODS: The results of screening have been disappointing. A critical review of relevant publications is given. RESUL...<br/><br/>Bjørn Moum (2002) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 122: 27 2624-2626<br/>

http://publicationslist.org/b.moum/refid15 2010-06-19T08:20:54Z

BACKGROUND: The use of quality of life (QoL) questionnaires in clinical medicine must be based on instruments that are reliable and valid. The aim of this study was to describe the translation of the Inflammatory Bowel Disease Questionnaire (IBDQ) into Norwegian, its scaling assumptions and the psychometric properties of the translated questionnaire. METHOD: All patients included were recruited fr...<br/><br/>T Bernklev, B Moum, T Moum (2002) <i>Scand J Gastroenterol</i> <i></i> <i></i> 37: 10 1164-1174<br/>

http://publicationslist.org/b.moum/refid16 2010-06-19T08:20:54Z

OBJECTIVE: To study the prevalence of Sjögren's syndrome (SS), tear and saliva production and sicca symptoms in patients with inflammatory bowel disease (IBD) seen six years after IBD diagnosis. METHODS: In a population based cohort of 654 patients with IBD, 521 patients (80%) and a control group consisting of 68 healthy subjects were investigated. SS was diagnosed according to the European Crite...<br/><br/>Øyvind Palm, Bjørn Moum, Jan Tore Gran (2002) <i>Scand J Rheumatol</i> <i></i> <i></i> 31: 3 140-145<br/>

http://publicationslist.org/b.moum/refid25 2010-06-19T08:20:54Z

B Moum (2001) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 121: 11 <br/>

http://publicationslist.org/b.moum/refid26 2010-06-19T08:20:54Z

OBJECTIVE: To assess the prevalence of fibromyalgia (FM) and chronic widespread pain (CWP) in a population based cohort of patients with inflammatory bowel disease (IBD). METHODS: Patients in a prospective survey on newly diagnosed IBD were, 5 years after study entry, invited to a clinical examination including the investigation of musculoskeletal manifestations. A total of 521 patients were exami...<br/><br/>O Palm, B Moum, J Jahnsen, J T Gran (2001) <i>J Rheumatol</i> <i></i> <i></i> 28: 3 590-594<br/>

http://publicationslist.org/b.moum/refid24 2010-06-19T08:20:54Z

OBJECTIVES: To estimate the occurrence of peripheral arthritis (PA) 6 yr after diagnosis of inflammatory bowel disease (IBD). METHODS: In a population-based cohort of 654 patients with a definite diagnosis of IBD, 521 patients (80%) were clinically examined by a rheumatologist 6 yr after IBD diagnosis. RESULTS: PA related to IBD (PAIBD) was detected at examination in four patients (point prevalenc...<br/><br/>Ø Palm, B Moum, J Jahnsen, J T Gran (2001) <i>Rheumatology (Oxford)</i> <i></i> <i></i> 40: 11 1256-1261<br/>

http://publicationslist.org/b.moum/refid22 2010-06-19T08:20:54Z

BACKGROUND: Endoscopy is the cornerstone of the diagnosis and treatment of acute conditions in the upper part of the gastrointestinal tract. The need for 24-hour availability of gastroscopy for these conditions has not previously been assessed. MATERIAL AND METHODS: We assessed the need for emergency gastroscopy in cases of acute upper gastrointestinal bleeding and obstruction by foreign bodies. T...<br/><br/>B Moum, T Hauge, F Lerang, P Sandvei, M Henriksen, T Pettersen (2001) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 121: 29 3396-3398<br/>

http://publicationslist.org/b.moum/refid28 2010-06-19T08:20:54Z

BACKGROUND, MATERIAL AND METHODS: Most studies of the prognosis of inflammatory bowel disease have not been population-based; they are retrospective reviews. Moreover, they lack uniform methods for assessment of outcome. The clinical course is difficult to predict and the prognosis has changed over the last decades as a result of progress in medical therapeutics and treatment principles and surgic...<br/><br/>B Moum (2001) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 121: 3 318-321<br/>

http://publicationslist.org/b.moum/refid23 2010-06-19T08:20:54Z

OBJECTIVES: As inflammatory bowel disease is a chronic disorder, usually with an early onset in life, quality of care plays an important role for patients. The aim of this study was to develop a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease. METHODS: Ten generic questions were already available because the questionnaire is based on an existin...<br/><br/>I van der Eijk, H Sixma, T Smeets, F T Veloso, S Odes, S Montague, G Fornaciari, B Moum, R Stockbrügger, M Russel (2001) <i>Am J Gastroenterol</i> <i></i> <i></i> 96: 12 3329-3336<br/>

http://publicationslist.org/b.moum/refid27 2010-06-19T08:20:54Z

BACKGROUND: About one quarter of women with the diagnosis conceive after the diagnosis has been made, and patients and clinicians are concerned about the health of the foetus and the possible side effects of medical and surgical treatment. MATERIAL, METHODS AND RESULTS: A survey of the literature shows that the general outlook is positive. The lifetime risk of developing inflammatory bowel disease...<br/><br/>B Moum (2001) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 121: 3 322-325<br/>

http://publicationslist.org/b.moum/refid29 2010-06-19T08:20:54Z

BACKGROUND: Most patients with gastro-oesophageal reflux disease (GERD), regardless of endoscopic status, suffer symptomatic relapse within 6 months of stopping acid suppressant therapy. AIM: To assess the efficacy of 'on-demand' treatment of GERD with esomeprazole, the first proton pump inhibitor developed as an optical isomer. METHODS: In this multicentre, double-blind study, 342 endoscopy-negat...<br/><br/>N J Talley, K Lauritsen, H Tunturi-Hihnala, T Lind, B Moum, C Bang, T Schulz, T M Omland, M Delle, O Junghard (2001) <i>Aliment Pharmacol Ther</i> <i></i> <i></i> 15: 3 347-354<br/>

http://publicationslist.org/b.moum/refid33 2010-06-19T08:20:54Z

Gastrooesophageal reflux disease has a variety of symptoms in children. 24-hour pH monitoring in the lower oesophagus is the gold standard for documenting gastrooesophageal reflux. We present our experience with 24-hour pH monitoring in children. 150 pH recordings in 120 children were performed. Clinical background and results from pH monitoring were recorded, in addition to supplementary examinat...<br/><br/>K Størdal, B Bentsen, H Skulstad, B Moum (2000) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 120: 2 183-186<br/>

http://publicationslist.org/b.moum/refid32 2010-06-19T08:20:54Z

BACKGROUND: By argon plasma coagulation (APC), a current is applied to tissues as ionised gas. Special probes have recently been developed for applying the gas through flexible endoscopes. In the field of therapeutic endoscopy, this method is promising for several diseases in the gastrointestinal tract. MATERIAL AND METHODS: At Ostfold Hospital in Fredrikstad, Norway, 122 treatments in 80 patients...<br/><br/>T Hauge, B Moum, P Sandvei, F Lerang, P Ravneng (2000) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 120: 12 1413-1415<br/>

http://publicationslist.org/b.moum/refid31 2010-06-19T08:20:54Z

It is difficult to predict the clinical course of inflammatory bowel disease (IBD). Moderately sick Crohn's disease (CD) patients and patients with distal ulcerative colitis (UC) may get better even without medical or surgical treatment. Once better, they may continue in remission even without treatment. If they are not treated, there are several factors that predict whether they will maintain rem...<br/><br/> Moum (2000) <i>Eur J Intern Med</i> <i></i> <i></i> 11: 4 197-203<br/>

http://publicationslist.org/b.moum/refid30 2010-06-19T08:20:54Z

B Moum (2000) <i>Scand J Gastroenterol</i> <i></i> <i></i> 35: 7 673-678<br/>

http://publicationslist.org/b.moum/refid34 2010-06-19T08:20:54Z

OBJECTIVE: Colonoscopy has replaced barium enema as the method for determining the extent of disease in patients with ulcerative colitis (UC). Normally, the extent of disease is determined by direct visualization of the mucosa, but biopsies are also used with increasing frequency. Very little is known about the extent to which these two ways of assessing the extent of disease are correlated and wh...<br/><br/>B Moum, A Ekbom, M H Vatn, K Elgjo (1999) <i>Am J Gastroenterol</i> <i></i> <i></i> 94: 6 1564-1569<br/>

http://publicationslist.org/b.moum/refid36 2010-06-19T08:20:54Z

BACKGROUND: In this study we compared the accuracy of seven diagnostic tests in diagnosing Helicobacter pylori infection. METHODS: Over 1 year 351 consecutive dyspeptic patients were tested for H. pylori infection by means of antral biopsy specimens for the rapid urease test (RUT), culture, microscopy (acridine stain), and the laboratory urease test (LUT) and, in addition, with 14C urea breath tes...<br/><br/>F Lerang, B Moum, P Mowinckel, J B Haug, E Ragnhildstveit, T Berge, A Bjørneklett (1998) <i>Scand J Gastroenterol</i> <i></i> <i></i> 33: 4 364-369<br/>

http://publicationslist.org/b.moum/refid37 2010-06-19T08:20:54Z

OBJECTIVE: To evaluate the cure rate of Helicobacter pylori infection, including the impact of in vitro metronidazole resistance (M-R), and the side effects of a simplified 10-day bismuth triple therapy in routine clinical practice. METHODS: From September 1995 to March 1996, 248 consecutive H. pylori-positive patients received 10 days of bismuth subnitrate 150 mg, oxytetracycline 500 mg, and metr...<br/><br/>F Lerang, B Moum, E Ragnhildstveit, P K Sandvei, P Tolås, J E Whist, M Henriksen, J B Haug, T Berge (1998) <i>Am J Gastroenterol</i> <i></i> <i></i> 93: 2 212-216<br/>

http://publicationslist.org/b.moum/refid35 2010-06-19T08:20:54Z

BACKGROUND: In this study we assessed the accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. METHODS: The outcome of anti-H. pylori therapy was established by at least two of the following tests: rapid urease test (RUT), culture, 14C urea breath test (non-capsule or capsule UBT), and IgG serology (Orion Diagnostica Pyloriset New EIA-G). RESULTS: Successful H. p...<br/><br/>F Lerang, J B Haug, B Moum, P Mowinckel, T Berge, E Ragnhildstveit, A Bjørneklett (1998) <i>Scand J Gastroenterol</i> <i></i> <i></i> 33: 7 710-715<br/>

http://publicationslist.org/b.moum/refid42 2010-06-19T08:20:54Z

OBJECTIVES: To compare the efficacy and side effects of standard bismuth triple therapy with those of omeprazole-based triple therapy in patients with Helicobacter pylori infection and duodenal ulcer disease. METHODS: One hundred patients were prospectively recruited and randomized to receive either bismuth subnitrate 75 mg q.i.d., oxytetracycline 500 mg q.i.d., and metronidazole 400 mg b.i.d. (re...<br/><br/>F Lerang, B Moum, E Ragnhildstveit, J B Haug, T Hauge, P Tolås, E Aubert, M Henriksen, P S Efskind, K Nicolaysen, T Søberg, A Odegaard, T Berge (1997) <i>Am J Gastroenterol</i> <i></i> <i></i> 92: 4 653-658<br/>

http://publicationslist.org/b.moum/refid44 2010-06-19T08:20:54Z

OBJECTIVES: To compare cure rates of Helicobacter pylori (H. pylori) infection, ulcer healing, and side effects of three simplified regimens of triple therapy in patients with peptic ulcer disease. METHODS: Two hundred thirty-one patients were prospectively randomized to receive either regimen OAM (omeprazole 20 mg b.i.d., amoxicillin 750 mg b.i.d., and metronidazole 400 g b.i.d.), OCM (omeprazole...<br/><br/>F Lerang, B Moum, J B Haug, P Tolås, O Breder, E Aubert, O Høie, T Søberg, B Flaaten, P Farup, T Berge (1997) <i>Am J Gastroenterol</i> <i></i> <i></i> 92: 2 248-253<br/>

http://publicationslist.org/b.moum/refid43 2010-06-19T08:20:54Z

BACKGROUND: The incidence figures for ulcerative colitis (UC) and Crohn's disease (CD) have been difficult to interpret, and geographical variations may be due to differences in classification criteria and study design. Few studies have based the incidence on prospective systematic follow up to confirm the initial diagnosis. METHODS: Between 1990 and 1993, in a prospective incidence study of infla...<br/><br/>B Moum, A Ekbom, M H Vatn, E Aadland, J Sauar, I Lygren, T Schulz, N Stray, O Fausa (1997) <i>Gut</i> <i></i> <i></i> 40: 3 328-332<br/>

http://publicationslist.org/b.moum/refid41 2010-06-19T08:20:54Z

BACKGROUND: The clinical course and prognosis in ulcerative colitis (UC) and Crohn's disease (CD) have been described in many studies, mostly retrospective. Such studies are hampered by problems such as inclusion over a long time period, proper definitions, incomplete case records, and outdated methods of diagnosis. In a prospective study we identified 846 patients with inflammatory bowel disease ...<br/><br/>B Moum, A Ekbom, M H Vatn, E Aadland, J Sauar, I Lygren, T Schulz, N Stray, O Fausa (1997) <i>Scand J Gastroenterol</i> <i></i> <i></i> 32: 10 1005-1012<br/>

http://publicationslist.org/b.moum/refid40 2010-06-19T08:20:54Z

B Moum (1997) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 117: 22 3262-3263<br/>

http://publicationslist.org/b.moum/refid38 2010-06-19T08:20:54Z

BACKGROUND: In this study we compared the cure rates of two clarithromycin-based regimens in patients in whom anti-Helicobacter pylori therapy had previously failed. METHODS: Thirty-three patients were randomized to receive either regimen OAC (20 mg omeprazole, 750 mg amoxicillin, and 250 mg clarithromycin) or BTC (240 mg bismuth subcitrate, 750 mg oxytetracycline, and 250 mg clarithromycin), all ...<br/><br/>F Lerang, B Moum, J B Haug, T Berge, P Tolås, P K Sandvei, R Torp, T Tønnesen (1997) <i>Scand J Gastroenterol</i> <i></i> <i></i> 32: 12 1209-1214<br/>

http://publicationslist.org/b.moum/refid39 2010-06-19T08:20:54Z

A 77 year-old man developed intermittent diarrhoea and malabsorption. Endoscopic findings and preliminary histological examination indicated ulcerative colitis. Special staining of biopsies from the duodenum and colon revealed amyloid deposits. Classification of the amyloid fibril protein verified AL-amyloidosis, and the diagnosis primary idiopathic amyloidosis was made. Amyloid deposit in the gas...<br/><br/>H Skulstad, M B Jacobsen, B Moum, A Odegaard (1997) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 117: 24 3489-3491<br/>

http://publicationslist.org/b.moum/refid45 2010-06-19T08:20:54Z

BACKGROUND: The incidence of ulcerative colitis (UC) has been difficult to interpret because prospective studies have only been performed during the past 3 decades. Geographic variations may therefore be due to differences in study design. METHOD: From 1 January 1990 to 31 December 1993 all new cases of UC in four counties in southeastern Norway were prospectively registered. Cases diagnosed as in...<br/><br/>B Moum, M H Vatn, A Ekbom, E Aadland, O Fausa, I Lygren, J Sauar, T Schulz, N Stray (1996) <i>Scand J Gastroenterol</i> <i></i> <i></i> 31: 4 362-366<br/>

http://publicationslist.org/b.moum/refid46 2010-06-19T08:20:54Z

BACKGROUND: Standardized criteria for Crohn's disease (CD) have only recently been developed, and prospective community-based incidence studies have been performed only during the past 3 decades. Geographic variations in incidence may therefore be due to differences in study design. METHODS: From 1 January 1990 to 31 December 1993 all new cases of CD in four counties in southeastern Norway were pr...<br/><br/>B Moum, M H Vatn, A Ekbom, E Aadland, O Fausa, I Lygren, N Stray, J Sauar, T Schulz (1996) <i>Scand J Gastroenterol</i> <i></i> <i></i> 31: 4 355-361<br/>

http://publicationslist.org/b.moum/refid47 2010-06-19T08:20:54Z

Several retrospective studies have reported seasonal variations in the relapse of ulcerative colitis, and two studies have found seasonality in the onset of ulcerative colitis, with a peak from August to January. This study was designed to investigate possible seasonal variations of onset of ulcerative colitis (UC) and Crohn's disease (CD). Patients with symptoms of one year or less were recruited...<br/><br/>B Moum, E Aadland, A Ekbom, M H Vatn (1996) <i>Gut</i> <i></i> <i></i> 38: 3 376-378<br/>

http://publicationslist.org/b.moum/refid48 2010-06-19T08:20:54Z

To assess the feasibility of a prospective incidence study of inflammatory bowel disease (IBD), the registration methods and incidence figures during 1990 were evaluated. The study was a collaboration between 14 hospitals in an area of close to one million inhabitants. Common diagnostic criteria for ulcerative colitis (UC), Crohn's disease (CD) and indeterminate colitis (IND) were established prio...<br/><br/>B Moum, M H Vatn, A Ekbom, O Fausa, E Aadland, I Lygren, J Sauar, T Schulz (1995) <i>Digestion</i> <i></i> <i></i> 56: 5 377-381<br/>

http://publicationslist.org/b.moum/refid49 2010-06-19T08:20:54Z

F Lerang, B Moum, E Ragnhildstveit (1994) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 114: 12 <br/>

http://publicationslist.org/b.moum/refid50 2010-06-19T08:20:54Z

Side effects of herbal and health food products have been infrequently reported such as hepatic damage after use of such products. Four such patients were treated in our department in the course of two years. In all four patients, the use of herbal remedies was the probable cause of serious hepatic damage, but both etiology and pathogenesis were difficult to establish. Two major areas of concern a...<br/><br/>B Moum, P Aukrust, E Schrumpf, T Mørk, O Mathisen, K Elgjo (1992) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 112: 10 1308-1311<br/>

http://publicationslist.org/b.moum/refid53 2010-06-19T08:20:54Z

During a seven-year period, symptomatic cytomegalovirus (CMV)-infection was diagnosed in 21.5% (n = 10) of all AIDS patients at the National Hospital of Norway (retinitis n = 8, colitis n = 3, pneumonitis n = 2, gastritis n = 1). Symptomatic cytomegalovirus-infection was associated with a poor long-term prognosis (median survival 174 days, range 10-415). Median CD4+ lymphocyte counts at onset of s...<br/><br/>P Aukrust, S S Frøland, D Kvale, K Egge, I N Farstad, E Holter, B Moum (1991) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 111: 28 3379-3384<br/>

http://publicationslist.org/b.moum/refid54 2010-06-19T08:20:54Z

Cytomegalovirus (CMV) colitis is uncommon in patients who are not gravely immunodepressed. We report a case of fatal CMV colitis in a 54-year-old woman on low dose steroid therapy. She was admitted to hospital after sudden onset of abdominal pain and hemorrhagic watery diarrhea. After 25 days in the hospital, treatment with high dosage of methylprednisolone was started for presumed ulcerative coli...<br/><br/>P Aukrust, B Moum, I N Farstad, E Holter, A Bjørneklett, D Kremer (1991) <i>Scand J Infect Dis</i> <i></i> <i></i> 23: 4 495-499<br/>

http://publicationslist.org/b.moum/refid52 2010-06-19T08:20:54Z

Cytomegalovirus infections in immunocompromised patients may cause serious illness, particularly in patients with HIV-disease and in transplant recipients. There is an increasing number of reports of cytomegalovirus infections involving the alimentary tract, especially colitis. Diagnosis of cytomegalovirus disease is at present based on specific histological findings. Antibody findings can be diff...<br/><br/>B Moum, P Aukrust, A Bjørneklett, S S Frøland, I N Farstad, E Holter (1991) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 111: 28 3388-3391<br/>

http://publicationslist.org/b.moum/refid51 2010-06-19T08:20:54Z

Cytomegalovirus disease is seen mainly in immunocompromised patients. While gastrointestinal symptoms are difficult to interpret, the typical finding at endoscopy of the upper alimentary tract is ulcers. Diagnosis of cytomegalovirus disease is based on typical histological findings in biopsy specimens. Antiviral treatment should be started when cytomegalovirus disease is detected in transplant pat...<br/><br/>B Moum, P Aukrust, O Fausa, I N Farstad, E Holter (1991) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 111: 28 3391-3393<br/>

http://publicationslist.org/b.moum/refid55 2010-06-19T08:20:54Z

B Moum (1984) <i>Tidsskr Nor Laegeforen</i> <i></i> <i></i> 104: 24 1663-1664<br/>